These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 878901)

  • 1. [Immunochemical determination of some complement components in sera studied at various temperatures].
    Miletić VD; Jelić S; Plećass V
    Acta Med Iugosl; 1977; 31(2):137-48. PubMed ID: 878901
    [No Abstract]   [Full Text] [Related]  

  • 2. [Progress in the methods of isolation and purification of complement components].
    Takahashi K; Nagasawa S
    Nihon Rinsho; 1979 May; 37(5):937-42. PubMed ID: 381724
    [No Abstract]   [Full Text] [Related]  

  • 3. [Complement pattern in children with allergic-toxic exanthema--a contribution to differential diagnosis (author's transl)].
    Lubec G; Ratzehofer E
    Padiatr Padol; 1977; 12(3):292-3. PubMed ID: 408779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and quantitation in plasma and synovial fluid of a fragment of human C4 with alpha mobility generated during the activation of the complement system.
    Perrin LH; Shiraishi S; Stroud RM; Lambert PH
    J Immunol; 1975 Jul; 115(1):32-5. PubMed ID: 1171140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activity of total complement and concentration of its components C1q, C3, C4 and C1-inactivator in cancer].
    Matoses Cuquerella S; O'Connor Miquel C; Lluch Hernández AM; García-Conde Bru J
    Med Clin (Barc); 1988 Dec; 91(20):769-74. PubMed ID: 3266280
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunochemical determination of human complement C3 fraction].
    Shchegoleva IA; Chebotkevich VN
    Lab Delo; 1980; (9):542-3. PubMed ID: 6157925
    [No Abstract]   [Full Text] [Related]  

  • 7. Levels of some complement components in azoospermic, oligospermic and normospermic Nigerian men.
    Oyeyinka GO; Bello CS; Elegba OY; Nsofor BI
    J Reprod Med; 1987 Oct; 32(10):774-6. PubMed ID: 3500310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
    Sheĭtanov I; Nikolov K; Petrova P
    Vutr Boles; 1987; 26(4):66-70. PubMed ID: 3499707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of the serum levels of complement during the first year of life].
    Pedraz C; Lorente F; Pedraz MJ; Salazar Villalobos V
    An Esp Pediatr; 1980 Jul; 13(7):571-6. PubMed ID: 7416647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.
    Perrin LH; Lambert PH; Miescher PA
    J Clin Invest; 1975 Jul; 56(1):165-76. PubMed ID: 1141431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clearances of complement components, C3 proactivator and other serum proteins in chronic membranoproliferative glomerulonephritis (CMPGN).
    Geiger H; Good RA; Day NK
    Clin Nephrol; 1975; 3(4):139-47. PubMed ID: 1149337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of aging on complement activity (CH50) and complement protein levels.
    Nagaki K; Hiramatsu S; Inai S; Sasaki A
    J Clin Lab Immunol; 1980 Jan; 3(1):45-50. PubMed ID: 7381926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
    Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
    Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Formation of classical C3 convertase during the alternative pathway of human complement activation].
    Kozlov LV; Shibanova ED; Zinchenko AA
    Biokhimiia; 1987 Apr; 52(4):660-6. PubMed ID: 3647798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The activation of the complement system in various connective tissue diseases].
    del Rey Calero J; Garcia de Lomas J; Vázquez Rodriguez JJ; Gómez Morillo O; Garcia de Lomas E; DEL Rio A
    Allergol Immunopathol (Madr); 1975; 3(6):431-44. PubMed ID: 1221827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activating cryoglobulins in the nephritis of systemic lupus erythematosus.
    Adu D; Williams DG
    Clin Exp Immunol; 1984 Mar; 55(3):495-501. PubMed ID: 6705265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of various fractions of complement (Cl, C3c, C3a, C4) in a population of healthy neonates].
    Zito GA; Grano S; Gallo AB; Papaleo G; Tripodi V
    Boll Soc Ital Biol Sper; 1982 Aug; 58(16):1043-7. PubMed ID: 6982719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum concentrations of immunoglobulins and complement components in patients with recurrence after resection of gastric carcinoma.
    Janssen CW; Tønder O; Matre R
    Cancer Detect Prev; 1987; 10(3-4):303-9. PubMed ID: 3568028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement activation in patients with Gambian sleeping sickness.
    Greenwood BM; Whittle HC
    Clin Exp Immunol; 1976 Apr; 24(1):133-8. PubMed ID: 949871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.